Literature DB >> 33649194

Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.

Carolina M Voloch1, Ronaldo da Silva Francisco2, Luiz G P de Almeida2, Cynthia C Cardoso1, Otavio J Brustolini2, Alexandra L Gerber2, Ana Paula de C Guimarães2, Diana Mariani1, Raissa Mirella da Costa1, Orlando C Ferreira1, Thiago Silva Frauches3, Claudia Maria Braga de Mello4, Isabela de Carvalho Leitão5, Rafael Mello Galliez6, Débora Souza Faffe5, Terezinha M P P Castiñeiras6, Amilcar Tanuri7, Ana Tereza R de Vasconcelos8.   

Abstract

Almost simultaneously, several studies reported the emergence of novel SARS-CoV-2 lineages characterized by their phylogenetic and genetic distinction (1), (2), (3), (4).….
Copyright © 2021 Voloch et al.

Entities:  

Year:  2021        PMID: 33649194      PMCID: PMC8139668          DOI: 10.1128/JVI.00119-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


LETTER

Almost simultaneously, several studies reported the emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages characterized by distinct phylogenetic and genetic features (1–4). Here, we sequenced 180 complete genomes collected between April and November 2020 from the Brazilian state of Rio de Janeiro (see Table S1 in the supplemental material) and identified 37 samples composing a new variant lineage. This novel lineage, currently classified as P.2 by Pangolin (COG-UK), a descendant of the B.1.1.28 strain, is distinguished by five lineage-defining mutations: 5′ untranslated region [UTR] C100U, (ORF1ab L3468V, ORF1ab synC11824U, S E484K, and N A119S). Five other mutations were also detected in many genomes from this lineage (ORF1ab L3930F, ORF1ab synA12964G, ORF8 synC28253U, N M234I, and 3′ UTR C29754U). We found a total of 731 single-nucleotide variants (SNVs) across the 180 samples, of which 50.3% were missense, 44.5% synonymous, 5.1% intergenic, and 0.1% nonsense. For the phylogenetic reconstruction, we gathered a global data set containing the 180 new genomes plus 1,197 high-coverage genomes from GISAID (GISAID Initiative; see Table S2), including 116 Brazilian and 1,081 worldwide genomes whose collection dates ranged from May to November (data downloaded 3 December 2020). Genomes were classified using Pangolin (COG-UK). The phylogenetic reconstruction indicates that the vast majority (86.8%) of Brazilian genomes fall within three clades (Fig. 1). Clade I comprises B.1.1.33 strains, while clades II and III are composed of B.1.1.28 strains. We inferred that P.2 falls within clade II (Fig. 1) and emerged in July 2020.
FIG 1

Phylogeny and timescale of P.2 lineage. (A) Maximum-likelihood tree of 1,377 SARS-CoV-2 genomes, including the 180 new Brazilian genomes generated in this work. We randomly sampled one genome/week/country from available samples in GISAID with collection dates ranging from May to November. Brazilian sequences with collection dates from May to November were all added to the data set (see Table S2). We ran IQTree 2.0.3 (10) under a general time-reversible (GTR) model of nucleotide substitution (11) with empirical base frequencies and invariant sites. Tips are colored according to their origin. Genomes generated from this work are red, other Brazilian genomes are blue, and genomes from other countries are not colored. Gray areas represent the three clades where Brazilian viruses are concentrated. The emergent lineage identified in this work, P.2, is in a dark-gray box and highlighted with red branches. The approximate likelihood ratio test (aLRT) support value for the branch holding P.2 monophyly is shown. (B) A time-scaled tree of clade II was estimated under a strict molecular clock in BEAST v.1.10.4 (12) using the GTR+I (11) nucleotide substitution model and assuming an exponential growth tree prior and a normal prior for the clock rate (mean = 8 × 10−4 and standard deviation = 0.1 × 10−5). The convergence of the Markov chain Monte Carlo chains, which were run at least for 50 million generations and sampled every 1,000th step, was inspected using Tracer v.1.7.1 (13). Maximum clade credibility (MCC) summary trees were generated using TreeAnnotator v.1.10.4 (12). Red circles in the tip nodes represent genomes generated in this work, and blue circles indicate other Brazilian samples. P.2 is identified by the red branches and highlighted in a gray box. The posterior probability of the branch holding P.2 monophyly is shown.

Phylogeny and timescale of P.2 lineage. (A) Maximum-likelihood tree of 1,377 SARS-CoV-2 genomes, including the 180 new Brazilian genomes generated in this work. We randomly sampled one genome/week/country from available samples in GISAID with collection dates ranging from May to November. Brazilian sequences with collection dates from May to November were all added to the data set (see Table S2). We ran IQTree 2.0.3 (10) under a general time-reversible (GTR) model of nucleotide substitution (11) with empirical base frequencies and invariant sites. Tips are colored according to their origin. Genomes generated from this work are red, other Brazilian genomes are blue, and genomes from other countries are not colored. Gray areas represent the three clades where Brazilian viruses are concentrated. The emergent lineage identified in this work, P.2, is in a dark-gray box and highlighted with red branches. The approximate likelihood ratio test (aLRT) support value for the branch holding P.2 monophyly is shown. (B) A time-scaled tree of clade II was estimated under a strict molecular clock in BEAST v.1.10.4 (12) using the GTR+I (11) nucleotide substitution model and assuming an exponential growth tree prior and a normal prior for the clock rate (mean = 8 × 10−4 and standard deviation = 0.1 × 10−5). The convergence of the Markov chain Monte Carlo chains, which were run at least for 50 million generations and sampled every 1,000th step, was inspected using Tracer v.1.7.1 (13). Maximum clade credibility (MCC) summary trees were generated using TreeAnnotator v.1.10.4 (12). Red circles in the tip nodes represent genomes generated in this work, and blue circles indicate other Brazilian samples. P.2 is identified by the red branches and highlighted in a gray box. The posterior probability of the branch holding P.2 monophyly is shown. An essential feature of the new strains recently described in the United Kingdom (B.1.1.7) (1), South Africa (B.1.351) (2), and Brazil (P.1) (3, 4) is that they have a unique set of multiple spike mutations, including N501Y, which is associated with greater infectivity and transmissibility. In contrast, all P.2 genomes exhibit only E484K in addition to a varying collection of either novel or rarely found spike mutations. E484K is also present in P.1 and B.1.351 lineages, but not in B.1.1.7. Since both P.1 and P.2 lineages are descendants of B.1.1.28 and both were first detected in Brazil, we performed a phylogenetic analysis of all their genomes available in GISAID (data downloaded 11 February 2021). Figure 2 highlights the differences between them and their origin, showing that despite sharing E484K, both emerged from independent events. The localities where these two lineages were first detected have had entirely different epidemiological dynamics since the beginning of coronavirus disease 2019 (COVID-19) history in Brazil (5); therefore, the two variants arose independently in different epidemiological contexts.
FIG 2

Phylogeny of B.1.1.28 and its alias lineages (P.1 and P.2). Maximum-likelihood tree of 993 SARS-CoV-2 genomes. We downloaded all B.1.1.28, P.1, and P.2 high-coverage genomes available in GISAID on 11 February 2021. The phylogeny was estimated using IQTree 2.0.3 (10) under a GTR+F+R3 model chosen by ModelFinder. Brazilian genomes are not tip colored. Viruses from other countries are colored according to their geographical origin (dark blue, South America; light blue, North America; dark green, Europe; light green, Africa; brown, Asia; and orange, Oceania). Gray areas highlight P.1 and P.2 lineages. The aLRT support value for the branch holding P.1 and P.2 monophyly is shown. The tree is rooted with 3 B.1.1 genomes. The chart shows the single nucleotide polymorphisms (SNPs) that characterize P.1 and P.2 lineages.

Phylogeny of B.1.1.28 and its alias lineages (P.1 and P.2). Maximum-likelihood tree of 993 SARS-CoV-2 genomes. We downloaded all B.1.1.28, P.1, and P.2 high-coverage genomes available in GISAID on 11 February 2021. The phylogeny was estimated using IQTree 2.0.3 (10) under a GTR+F+R3 model chosen by ModelFinder. Brazilian genomes are not tip colored. Viruses from other countries are colored according to their geographical origin (dark blue, South America; light blue, North America; dark green, Europe; light green, Africa; brown, Asia; and orange, Oceania). Gray areas highlight P.1 and P.2 lineages. The aLRT support value for the branch holding P.1 and P.2 monophyly is shown. The tree is rooted with 3 B.1.1 genomes. The chart shows the single nucleotide polymorphisms (SNPs) that characterize P.1 and P.2 lineages. The cases of reinfection involving the new variant lineage P.2 (6, 7) and the ability of viruses harboring the mutation E484K to escape from neutralizing antibodies (8, 9) emphasize the importance of monitoring the spread of this new strain. In about 4 months, 342 genomes classified as P.2 have become available. The emergent lineage P.2, initially detected in 37 samples from Rio de Janeiro State, is spread across all Brazilian regions and 16 other countries. Brazilian viruses are the oldest and constitute the majority (55%) of the P.2 genomes, suggesting its exportation worldwide. The present study was approved by the National Committee of Research Ethics and by the Ethics Committee of Hospital Universitário Clementino Fraga Filho (protocol numbers 30161620.0.1001.5257 and 34025020.0.0000.5257).

Data availability.

NGS data generated in our study are publicly available in SRA-NCBI (www.ncbi.nlm.nih.gov/sra), under BioProject accession no. PRJNA686081. Genome sequences were also deposited in GISAID (https://www.gisaid.org/) and are fully accessible for registered users within the “browse” option of the EpiCoV database (see Table S1).
  7 in total

1.  SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.

Authors:  Jinal N Bhiman; Penny L Moore; Constantinos Kurt Wibmer; Frances Ayres; Tandile Hermanus; Mashudu Madzivhandila; Prudence Kgagudi; Brent Oosthuysen; Bronwen E Lambson; Tulio de Oliveira; Marion Vermeulen; Karin van der Berg; Theresa Rossouw; Michael Boswell; Veronica Ueckermann; Susan Meiring; Anne von Gottberg; Cheryl Cohen; Lynn Morris
Journal:  Nat Med       Date:  2021-03-02       Impact factor: 53.440

2.  Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7.

Authors:  Andrew Rambaut; Alexei J Drummond; Dong Xie; Guy Baele; Marc A Suchard
Journal:  Syst Biol       Date:  2018-09-01       Impact factor: 15.683

3.  Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10.

Authors:  Marc A Suchard; Philippe Lemey; Guy Baele; Daniel L Ayres; Alexei J Drummond; Andrew Rambaut
Journal:  Virus Evol       Date:  2018-06-08

4.  IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era.

Authors:  Bui Quang Minh; Heiko A Schmidt; Olga Chernomor; Dominik Schrempf; Michael D Woodhams; Arndt von Haeseler; Robert Lanfear
Journal:  Mol Biol Evol       Date:  2020-05-01       Impact factor: 16.240

5.  Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.

Authors:  Lewis F Buss; Carlos A Prete; Claudia M M Abrahim; Alfredo Mendrone; Tassila Salomon; Cesar de Almeida-Neto; Rafael F O França; Maria C Belotti; Maria P S S Carvalho; Allyson G Costa; Myuki A E Crispim; Suzete C Ferreira; Nelson A Fraiji; Susie Gurzenda; Charles Whittaker; Leonardo T Kamaura; Pedro L Takecian; Pedro da Silva Peixoto; Marcio K Oikawa; Anna S Nishiya; Vanderson Rocha; Nanci A Salles; Andreza Aruska de Souza Santos; Martirene A da Silva; Brian Custer; Kris V Parag; Manoel Barral-Netto; Moritz U G Kraemer; Rafael H M Pereira; Oliver G Pybus; Michael P Busch; Márcia C Castro; Christopher Dye; Vítor H Nascimento; Nuno R Faria; Ester C Sabino
Journal:  Science       Date:  2020-12-08       Impact factor: 47.728

6.  Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.

Authors:  Carolina K V Nonaka; Marília Miranda Franco; Tiago Gräf; Camila Araújo de Lorenzo Barcia; Renata Naves de Ávila Mendonça; Karoline Almeida Felix de Sousa; Leila M C Neiva; Vagner Fosenca; Ana V A Mendes; Renato Santana de Aguiar; Marta Giovanetti; Bruno Solano de Freitas Souza
Journal:  Emerg Infect Dis       Date:  2021-02-19       Impact factor: 6.883

7.  Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.

Authors:  Allison J Greaney; Andrea N Loes; Katharine H D Crawford; Tyler N Starr; Keara D Malone; Helen Y Chu; Jesse D Bloom
Journal:  Cell Host Microbe       Date:  2021-02-08       Impact factor: 21.023

  7 in total
  130 in total

1.  How will emerging SARS-CoV-2 variants impact herd immunity?

Authors:  Giuseppe Lippi; Brandon M Henry
Journal:  Ann Transl Med       Date:  2021-04

2.  Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil.

Authors:  Vinícius Bonetti Franceschi; Gabriel Dickin Caldana; Amanda de Menezes Mayer; Gabriela Bettella Cybis; Carla Andretta Moreira Neves; Patrícia Aline Gröhs Ferrareze; Meriane Demoliner; Paula Rodrigues de Almeida; Juliana Schons Gularte; Alana Witt Hansen; Matheus Nunes Weber; Juliane Deise Fleck; Ricardo Ariel Zimerman; Lívia Kmetzsch; Fernando Rosado Spilki; Claudia Elizabeth Thompson
Journal:  BMC Genomics       Date:  2021-05-20       Impact factor: 3.969

3.  Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines.

Authors:  Yunlong Cao; Ayijiang Yisimayi; Yali Bai; Weijin Huang; Xiaofeng Li; Zhiying Zhang; Tianjiao Yuan; Ran An; Jing Wang; Tianhe Xiao; Shuo Du; Wenping Ma; Liyang Song; Yongzheng Li; Xiang Li; Weiliang Song; Jiajing Wu; Shuo Liu; Xuemei Li; Yonghong Zhang; Bin Su; Xianghua Guo; Yangyang Wei; Chuanping Gao; Nana Zhang; Yifei Zhang; Yang Dou; Xiaoyu Xu; Rui Shi; Bai Lu; Ronghua Jin; Yingmin Ma; Chengfeng Qin; Youchun Wang; Yingmei Feng; Junyu Xiao; Xiaoliang Sunney Xie
Journal:  Cell Res       Date:  2021-05-21       Impact factor: 25.617

Review 4.  50 Years of Structural Immunology.

Authors:  Ian A Wilson; Robyn L Stanfield
Journal:  J Biol Chem       Date:  2021-05-03       Impact factor: 5.157

5.  Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.

Authors:  Nuno R Faria; Thomas A Mellan; Charles Whittaker; Ingra M Claro; Darlan da S Candido; Swapnil Mishra; Oliver G Pybus; Seth Flaxman; Samir Bhatt; Ester C Sabino; Myuki A E Crispim; Flavia C S Sales; Iwona Hawryluk; John T McCrone; Ruben J G Hulswit; Lucas A M Franco; Mariana S Ramundo; Jaqueline G de Jesus; Pamela S Andrade; Thais M Coletti; Giulia M Ferreira; Camila A M Silva; Erika R Manuli; Rafael H M Pereira; Pedro S Peixoto; Moritz U G Kraemer; Nelson Gaburo; Cecilia da C Camilo; Henrique Hoeltgebaum; William M Souza; Esmenia C Rocha; Leandro M de Souza; Mariana C de Pinho; Leonardo J T Araujo; Frederico S V Malta; Aline B de Lima; Joice do P Silva; Danielle A G Zauli; Alessandro C de S Ferreira; Ricardo P Schnekenberg; Daniel J Laydon; Patrick G T Walker; Hannah M Schlüter; Ana L P Dos Santos; Maria S Vidal; Valentina S Del Caro; Rosinaldo M F Filho; Helem M Dos Santos; Renato S Aguiar; José L Proença-Modena; Bruce Nelson; James A Hay; Mélodie Monod; Xenia Miscouridou; Helen Coupland; Raphael Sonabend; Michaela Vollmer; Axel Gandy; Carlos A Prete; Vitor H Nascimento; Marc A Suchard; Thomas A Bowden; Sergei L K Pond; Chieh-Hsi Wu; Oliver Ratmann; Neil M Ferguson; Christopher Dye; Nick J Loman; Philippe Lemey; Andrew Rambaut; Nelson A Fraiji; Maria do P S S Carvalho
Journal:  Science       Date:  2021-04-14       Impact factor: 47.728

6.  Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation.

Authors:  Lauren M Meyers; Andres H Gutiérrez; Christine M Boyle; Frances Terry; Bethany G McGonnigal; Andres Salazar; Michael F Princiotta; Wiliam D Martin; Anne S De Groot; Leonard Moise
Journal:  NPJ Vaccines       Date:  2021-05-13       Impact factor: 7.344

7.  E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil.

Authors:  Patrícia Aline Gröhs Ferrareze; Vinícius Bonetti Franceschi; Amanda de Menezes Mayer; Gabriel Dickin Caldana; Ricardo Ariel Zimerman; Claudia Elizabeth Thompson
Journal:  Infect Genet Evol       Date:  2021-05-25       Impact factor: 4.393

8.  Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.

Authors:  Malik Sallam; Azmi Mahafzah
Journal:  Pathogens       Date:  2021-03-05

9.  First importations of SARS-CoV-2 P.1 and P.2 variants from Brazil to Spain and early community transmission.

Authors:  Pedro J Sola Campoy; Sergio Buenestado-Serrano; Laura Pérez-Lago; Cristina Rodriguez-Grande; Pilar Catalán; Cristina Andrés-Zayas; Luis Alcalá; Carmen Losada; Carla Rico-Luna; Patricia Muñoz; Darío García de Viedma
Journal:  Enferm Infecc Microbiol Clin       Date:  2021-06-03       Impact factor: 1.994

Review 10.  SARS-CoV-2 variants, spike mutations and immune escape.

Authors:  William T Harvey; Alessandro M Carabelli; Ben Jackson; Ravindra K Gupta; Emma C Thomson; Ewan M Harrison; Catherine Ludden; Richard Reeve; Andrew Rambaut; Sharon J Peacock; David L Robertson
Journal:  Nat Rev Microbiol       Date:  2021-06-01       Impact factor: 78.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.